ETH Zurich and Roche Pharma Research use AI to predict how pharmaceutically active molecules can be chemically modified to accelerate new pharma ingredient identification and optimize existing ingredients

Sample article from our Transformation & Innovation

December 5, 2023 (press release) –

A new AI model developed by chemists at ETH Zurich can not only predict where a pharmaceutically active molecule can be chemically modified, but also how best to do it.

 

 

* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.

More from our Transformation & Innovation Coverage
See our dashboard in action - schedule an demo
Chelsey Quick
Chelsey Quick
- VP Client Success -

We offer built-to-order transformation & innovation coverage for our clients. Contact us for a free consultation.

Sectors

Sectors

Channels

Channels

Consumer Markerts

Consumer Markets

Business Drivers

Business Drivers

About Us

We deliver market news & information relevant to your business.

We monitor all your market drivers.

We aggregate, curate, filter and map your specific needs.

We deliver the right information to the right person at the right time.

Latest Public Posts

Useful Links

Our Contacts

1990 S Bundy Dr. Suite #380,
Los Angeles, CA 90025

+1 (310) 553 0008

contact@industryintel.com
www.industryintel.com

About Cookies On This Site

We collect data, including through use of cookies and similar technology ("cookies") that enchance the online experience. By clicking "I agree", you agree to our cookies, agree to bound by our Terms of Use, and acknowledge our Privacy Policy. For more information on our data practices and how to exercise your privacy rights, please see our Privacy Policy.